Acumen Pharmaceuticals, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Acumen Pharmaceuticals, Inc. is a mid-sized biotechnology company based in Boston, Massachusetts, focused on advancing understanding and treatment of neurodegenerative diseases. The company centers its work on the biology of toxic soluble amyloid-beta oligomers, with the aim of developing therapies that address these species in Alzheimer's disease and related conditions. Its founders contributed early discoveries that linked toxic Aβ oligomers to synaptic dysfunction and neurodegeneration, helping position Acumen at the forefront of this research area. In March 2026, Acumen announced the development of anti-AβO antibodies with high selectivity for AβO over amyloid-beta monomers. The company engages with the research community through attendance and presentations at international conferences and industry forums, reflecting ongoing clinical-stage activity.